📄 Abstract
Asthma is a long-term inflammatory airway condition that frequently coexists with cardiovascular disorders, making treatment difficult, especially when beta blockers are required. By blockingß2-adrenergic receptors, beta blockers?especially non-selective ones?may worsen asthma by decreasing the effectiveness of bronchodilators. Conversely, asthma drugs, particularlyß2-agonists, may mitigate the beneficial effects of beta blockers on the heart. This study covers the causes, dangers, and evidence-based co-management techniques regarding the pharmacological and clinical interactions between beta blockers and asthma medications. This article provides physicians with a roadmap for navigating the intricate junction of respiratory and cardiovascular pharmacology, emphasizing pharmacodynamics, pharmacokinetics, and customized treatment.
🏷️ Keywords
📚 How to Cite:
Miss Komal Waghmare, Mr. Laxman Rathod , A COMPREHENSIVE REVIEW OF DRUG-DRUG INTERACTIONS BETWEEN ASTHMA MEDICATIONS AND BETA BLOCKERS: MECHANISMS, MANAGEMENT, AND CLINICAL CONSIDERATIONS , Volume 10 , Issue 5, may 2025, EPRA International Journal of Research & Development (IJRD) ,